Sonopet iQ Series III Console (5700-050-000); Sonopet iQ+ Straight Handpiece (5500-260-000); Sonopet iQ+ 10mm iQ+ Blade (5500-26B-010); Sonopet iQ+ 20mm iQ+ Blade (5500-26B-020); Sonopet iQ+ 11cm iQ+ Apex Knife (5500-26B-114); Sonopet iQ+ 12cm iQ+ Apex 360 (5500-26B-312); Sonopet iQ+ 12cm iQ+ Claw (5500-26B-328)
Stryker Instruments · Decision date Oct 8, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K262244 on October 8, 2026, submitted by Stryker Instruments of Portage, Michigan. The traditional 510(k) covers the Sonopet iQ Series III Ultrasonic Aspirator System, including the Series III console (5700-050-000), the iQ+ straight handpiece (5500-260-000) and five iQ+ hard tissue tips: 10 mm and 20 mm blades, an 11 cm Apex Knife, a 12 cm Apex 360 and a 12 cm Claw. The submission describes a next-generation system with device modifications and no change to fundamental scientific technology or intended use.
The filing lists predicate clearances K243930, K213824 and K190070 under product code LFL. The summary states that software testing followed IEC 62304 and that risk management followed ISO 14971, with pre-defined acceptance criteria met, and that no clinical testing was deemed necessary. SESE is a clearance, not a PMA approval. The specialty field is recorded as unknown, and the source does not provide independent performance data or current labeling beyond the stated indications.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Unknown
- Decision date
- Oct 8, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262244
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Stryker Instruments
- Product code
- LFL
- Decision code
- SESE
- Decision date
- Oct 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Instrument, Ultrasonic Surgical.
- Applicant
- Stryker Instruments
- Product code
- LFL
- FDA device class
- U
FDA decision timeline
K262244 received
Application receipt date recorded by FDA.
K262244 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LFL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Carl Zeiss Meditec, AG | 510(k) clearance | Oct 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Stryker Instruments
- Headquarters
- Not reported
- Brand website
- stryker.com
- FDA applicant address
- Portage, MI
Sources and methodology
- Original FDA record: K262244
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records